Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment >>

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon.
 
To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this link
 
The USD 4 billion (by 2030) financial opportunity within the microbiome therapeutics (Tx) market and diagnostics (Dx) markets, has been analyzed across the following segments:
Type of Therapy (Tx)
Prescription Drug
Prebiotics
Probiotics
Type of Molecule (Tx)
Small Molecules
Biologics
Target Indication (Tx+Dx)
Acne Vulgaris
Atopic Dermatitis
Clostridium difficile Infection
Colorectal Cancer
Crohn’s Disease
Diabetes
Irritable Bowel Syndrome
Lactose Intolerance
Lung Cancer
Nonalcoholic steatohepatitis (NASH)
Obesity
Ulcerative colitis
Therapeutic Area (Tx+Dx)
Autoimmune Disorders
Dental Disorders
Digestive and Gastrointestinal Disorders
Dermatological Disorders
Infectious Disease
Metabolic Disorders
Oncology
Others
Key Geographical Regions (Tx+Dx)
North America
Europe
Asia-Pacific and Rest of the World
 
 
The Human Microbiome Market, 2019-2030 report features the following companies, which we identified to be key players in this domain: 
  • 4D Pharma
  • Armata Pharmaceuticals
  • Evelo Biosciences
  • Rebiotix (Acquired by Ferring Pharmaceuticals)
  • Seres Therapeutics
  • Vedanta Biosciences
 
Table of Contents
Preface
 
Executive Summary
 
Introduction
 
Microbiome Therapeutics: Market Landscape
 
Company and Drug Profiles
 
Microbiome Diagnostics: Market Landscape
 
Fecal Microbiota Therapy (FMT)
 
Attractiveness Competitiveness (AC) Matrix
 
Microbiome Related Initiatives of Big Pharmaceutical Players
 
Start-up Health Indexing
 
Key Therapeutics Areas
 
Funding and Investment Analysis
 
Contract Services for Microbiome Therapeutics
 
Big Data and Microbiome Therapeutics
 
Microbiome Therapeutics: Market Forecast and Opportunity Analysis
 
Microbiome Diagnostics: Market Forecast and Opportunity Analysis
 
Fecal Microbiota Therapies: Market Forecast and Opportunity Analysis
 
Case Study: Microbiome-based Products in Other Industries
 
Concluding Remarks
 
Executive Insights
 
Appendix I: Tabulated Data
 
Appendix II: List of Companies and Organizations
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
732 Posts

Made with by Mamby